A systematic screen for micro-RNAs regulating the canonical Wnt pathway

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Anton, Roman ^a   Chatterjee, Sujash S ^a   Simundza, Julia ^a   Cowin, Pamela ^a   DasGupta, Ramanuj ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BETA GALACTOSIDASE; MICRORNA; MICRORNA 1; MICRORNA 25; MICRORNA 613; UNCLASSIFIED DRUG; WNT PROTEIN; MIRN1 MICRORNA, HUMAN; MIRN25 MICRORNA, HUMAN; MIRN613 MICRORNA, HUMAN;

ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CANCER CELL; CANCER SCREENING; CARCINOGENESIS; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FEMALE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE REPRESSION; GENETIC EPISTASIS; GENETIC SCREENING; HUMAN; HUMAN CELL; LENTIVIRINAE; MOUSE; NONHUMAN; REPORTER GENE; RNA ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS EXPRESSION; ANIMAL; DRUG EFFECT; DRUG SCREENING; GENETICS; METABOLISM; METHODOLOGY; NEOPLASM; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

MUS;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICRORNAS; NEOPLASMS; WNT SIGNALING PATHWAY;

EID: 80054773989     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026257     Document Type: Article

References (55)

1. Moser AR, Luongo C, Gould KA, McNeley MK, Shoemaker AR, et al. (1995) ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 31A: 1061-1064.
2. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Liu Q, Paroo Z, (2010) Biochemical Principles of Small RNA Pathways. Annu Rev Biochem.
4. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I, (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124-1128.
5. Visone R, Croce CM, (2009) MiRNAs and cancer. Am J Pathol 174: 1131-1138.
6. Liu W, Mao SY, Zhu WY, (2007) Impact of tiny miRNAs on cancers World. J Gastroenterol 13: 497 502.
7. O'Day E, Lal A, (2010) MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 19;12: 201.
8. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
9. Adams BD, Guttilla IK, White BA, (2008) Involvement of microRNAs in breast cancer. Semin Reprod Med 26: 522-536.
10. Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, et al. (2009) MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 219: 214-221.
11. Johnson, SM, Grosshans H, Shingara J, Byrom M, Jarvis R, et al. (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
12. Le MT, The C, Shyh-Chang N, Xie H, Zhou B, et al. (2009) MicroRNA-125b is a novel negative regulator of p53. Genes Dev 23: 862 876.
13. Zhang Y, Gao JS, Tang X, Tucker LD, Quesenberry P, et al. (2009) MicroRNA 125a and its regulation of the p53 tumor suppressor gene. FEBS Lett 19;583: 3725-3730.
14. Liu CC, Prior J, Piwnica-Worms D, Bu G, (2010) LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc Natl Acad Sci U S A 107: 5136 5141.
15. He B, Reguart N, You L, Mazieres J, Xu Z, et al. (2004) A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 6: 7-14.
16. Zhang J, Li Y, Liu Q, Lu W, Bu G, (2010) Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis. Oncogene 29: 539-549.
17. Bjorklund P, Svedlund J, Olsson AK, Akerstrom G, Westin G, (2009) The internally truncated LRP5 receptor presents a therapeutic target in breast cancer. PLoS One 4: e4243.
18. Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, et al. (2004) Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets 4: 653-671.
19. Quaiser T, Anton R, Kühl M, (2006) Kinases and G proteins join the Wnt receptor complex. Bioessays 28: 339-343.
20. Ryu MJ, Cho M, Song JY, Yun YS, Choi IW, et al. (2008) Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem Biophys Res Commun 377: 1304-1308.
21. Wieczorek M, Paczkowska A, Guzenda P, Majorek M, Bednarek AK, et al. (2008) Silencing of Wnt-1 by siRNA induces apoptosis of MCF-7 human breast cancer cells. Cancer Biol Ther 7: 268-274.
22. Hsi LC, Angerman-Stewart J, Eling TE, (1999) Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level. Carcinogenesis 20: 2045-2049.
23. Chen JS, Liang QM, Li HS, Yang J, Wang S, et al. (2009) Octreotide inhibits growth of colonic cancer SW480 cells by modulating the Wnt/β-catenin pathway. Pharmazie 64: 126-131.
24. Shan BE, Wang MX, Li RQ, (2009) Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest 27: 604-612.
25. Lu W, Tinsley HN, Keeton A, Qu Z, Piazza GA, et al. (2009) Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation. Eur J Pharmacol 602: 8-14.
26. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, et al. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
27. Tong AW, Nemunaitis J, (2008) Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 15: 341-355.
28. Silver SJ, Hagen JW, Okamura K, Perrimon N, Lai EC, (2007) Functional screening identifies miR-315 as a potent activator of Wingless signaling. Proc Natl Acad Sci U S A 104: 18151-6.
29. Xia H, Ng SS, Jiang S, Cheung WK, Sze J, et al. (2010) miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun 391: 535-541.
30. Kennell JA, Gerin I, MacDougald OA, Cadigan KM, (2008) The microRNA miR-8 is a conserved negative regulator of Wnt signaling. Proc Natl Acad Sci U S A 105: 15417-15422.
31. Wang T, Xu Z, (2010) miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun.
32. Saydam O, Shen Y, Würdinger T, Senol O, Broke E, et al. (2009) Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol 29: 5923-5940.
33. Thatcher EJ, Paydar I, Anderson KK, Patton JG, (2008) Regulation of zebrafish fin regeneration by microRNAs. Proc Natl Acad Sci U S A pp. 10518384-9.
34. Hashimi ST, Fulcher JA, Chang MH, Gov L, Wang S, et al. (2009) MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 114: 404-14.
35. Dasgupta R, Kaykas A, Moon RT, Perrimon N, (2005) Functional genomic analysis of the Wnt-wingless signaling pathway. Science 308: 826-833.
36. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, et al. (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448-452.
37. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, et al. (2002) Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 22: 1184-93.
38. Teissedre B, Pinderhughes A, Incassati A, Hatsell SJ, Hiremath M, et al. (2009) MMTV-Wnt1 and-ΔN89β-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors. PLoS One 4: e4537.
39. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, et al. (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132: 875-86.
40. Krieghoff E, Behrens J, Mayr B, (2006) Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. J Cell Sci 119: 1453 1463.
41. Cong F, Varmus H, (2004) Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin. Proc Natl Acad Sci U S A 101: 2882-2887.
42. Kan T, Sato F, Ito T, Matsumura N, David S, et al. (2009) The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 136: 1689-1700.
43. Kumar M, Lu Z, Takwi AA, Chen W, Callander NS, et al. (2010) Negative regulation of the tumor suppressor p53 gene by microRNAs Oncogene.
44. Hu W, Chan CS, Wu R, Zhang C, Sun Y, et al. (2010) Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell 38: 689-699.
45. Davidson G, Shen J, Huang YL, Su Y, Karaulanov E, et al. (2009) Cell cycle control of wnt receptor activation. Dev Cell 17: 788-99.
46. Xu WL, Wang Q, Du M, Zhao YH, Sun XR, et al. (2010) Growth inhibition effect of β-catenin small interfering RNA-mediated gene silencing on human colon carcinoma HT-29 cells. Cancer Biother Radiopharm 25: 529-37.
47. Chi SW, Zang JB, Mele A, Darnell RB, (2009) Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460: 479-486.
48. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129-141.
49. Yan D, Dong Xda E, Chen X, Wang L, Lu, et al. (2009) MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J Biol Chem 284: 29596-604.
50. Tuynman JB, Vermeulen L, Boon EM, Kemper K, Zwinderman AH, et al. (2008) Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer. Cancer Res 68: 1213-20.
51. Herynk MH, Tsan R, Radinsky R, Gallick GE, (2003) Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin. Clin Exp Metastasis 20: 291-300.
52. Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, et al. (2008) MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A 105: 12885-12890.
53. Ge X, Jin Q, Zhang F, Yan T, Zhai Q, (2009) PCAF acetylates β-catenin and improves its stability. Mol Biol Cell 20: 419-427.
54. He B, Requart N, You L, Mazieres J, Xu Z, et al. (2005) Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene 24: 3054-3058.
55. Kim SY, Dunn IF, Firestein R, Gupta P, Wardwell L, et al. (2010) CSK1epsilon is required for breast cancers dependent on b-catenin activity. Plos One 5 (2): e8979.